3013 SCIENCE PARK, SAN DIEGO, CA
Other Events
Appoints Greg Ciongoli to Board of Directors
Announces Effectiveness of 1-for-80 Reverse Stock Split
Announces 1-for-80 Reverse Stock Split
Bylaw Amendment - Gossamer Bio Reduces Quorum Requirement to One Third
Gossamer Bio, Inc. Amends Certificate of Incorporation for Series A-1 Stock
Announces Up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval
Q2
Q1
Q3
FY 2024
Notice of Exempt Offering of Securities
Effectiveness Notice
S-3ASR
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement
Submission Upload